53 filings
8-K
BVS
Bioventus Inc - Ordinary Shares
7 May 24
Bioventus Reports First Quarter Financial Results
7:33am
8-K
BVS
Bioventus Inc - Ordinary Shares
12 Mar 24
Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
BVS
Bioventus Inc - Ordinary Shares
19 Jan 24
Entry into a Material Definitive Agreement
8:27am
8-K
BVS
Bioventus Inc - Ordinary Shares
12 Jan 24
Departure of Directors or Certain Officers
5:10pm
8-K
BVS
Bioventus Inc - Ordinary Shares
21 Dec 23
Bioventus Names Robert Claypoole as President and Chief Executive Officer
8:00am
8-K
8f8jch hb
7 Nov 23
Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance
7:35am
8-K
9dn mtpgthfa68e1w
8 Aug 23
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
8:02am
8-K
q44lnutfq
9 Jun 23
Departure of Directors or Certain Officers
5:04pm
8-K
acihvsrkklivi8sp
26 May 23
Bioventus Completes Divestiture of its Wound Business
8:39am
8-K
yli75
16 May 23
Bioventus Reports First Quarter Financial Results
4:25pm
8-K
uu6t6detzm8kcx5c8
16 May 23
Bioventus Announces Divestiture of its Wound Business
8:15am
8-K
ke6e9jmfm vbmb1na
11 May 23
Results of Operations and Financial Condition
8:56am
8-K/A
ptyebn ydt
11 Apr 23
Departure of Directors or Certain Officers
5:17pm
8-K
o5ynbm 42rb7uafrar
5 Apr 23
Departure of Directors or Certain Officers
8:05am
8-K
7pafv5k yb3s
31 Mar 23
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
7:50am
8-K
6m18v3n7 dasyp
3 Mar 23
Completion of Acquisition or Disposition of Assets
5:14pm
8-K
ld6lcy9eba1vcx
28 Feb 23
Entry into a Material Definitive Agreement
7:30am
8-K
ta844w
9 Jan 23
Departure of Directors or Certain Officers
8:58am
8-K
jg5v6rb
7 Dec 22
Cost Associated with Exit or Disposal Activities
4:15pm
8-K/A
kush5
21 Nov 22
Bioventus Issues Revised Third Quarter Results; Updates Full-Year 2022 Financial Guidance
5:15pm